Filtered By:
Management: National Institutes of Health (NIH)

This page shows you your search results in order of date.

Order by Relevance | Date

Total 769 results found since Jan 2013.

News at a glance: A win for obesity drugs, NIH unionization roadblocks, and Mexican fireflies under threat
CONSERVATION Researchers raise alarm over threat to Mexican fireflies Scientists from the International Union for Conservation of Nature (IUCN) last week delivered a letter to the Mexican government requesting it regulate tourism centered on the threatened firefly species Photinus palaciosi . Endemic to Mexico’s Tlaxcala forests, P. palaciosi is one of the few species that glow in synchrony, offering an annual spectacle that attracts thousands of visitors during summer mating season. The letter describes how littering, artificial light, and noise interfere with the insects’ courtship and eg...
Source: ScienceNOW - August 10, 2023 Category: Science Source Type: news

News at a glance: A win for obesity drugs, a new infectious disease institute head, and Mexican fireflies under threat
CONSERVATION Researchers raise alarm over threat to Mexican fireflies Scientists from the International Union for Conservation of Nature (IUCN) last week delivered a letter to the Mexican government requesting it regulate tourism centered on the threatened firefly species Photinus palaciosi . Endemic to Mexico’s Tlaxcala forests, P. palaciosi is one of the few species that glow in synchrony, offering an annual spectacle that attracts thousands of visitors during summer mating season. The letter describes how littering, artificial light, and noise interfere with the insects’ courtship and eg...
Source: Science of Aging Knowledge Environment - August 10, 2023 Category: Geriatrics Source Type: research

HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

University of Alabama HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

NIH selects Dr. Jeanne Marrazzo as director of the National Institute of Allergy and Infectious Diseases
Dr. Marrazzo expected to begin her role as NIAID Director in the Fall.
Source: National Institutes of Health (NIH) News Releases - August 2, 2023 Category: American Health Source Type: news

Senate panel approves 2% bump for NIH budget in 2024
To the relief of biomedical research advocates, a Senate spending panel has approved a modest budget increase of 2% for the National Institutes of Health (NIH). The bump to $47.8 billion roughly matches President Joe Biden’s request for the 2024 fiscal year that begins this fall. Although below the rate of biomedical inflation, it is far more generous than a corresponding House of Representatives bill that would slash NIH’s budget by 6% . Advocacy groups welcomed the measure approved on 27 July by the Senate appropriations committee. “The Committee laid down an important marker for the appropriations...
Source: Science of Aging Knowledge Environment - July 28, 2023 Category: Geriatrics Source Type: research

Industry –sponsored research funding to allergists and clinical immunologists in the United States
Although allergist-immunologists have been facing difficulties to obtain funding for research and educational purposes from the public sector in the United States, there is a growing research collaboration and network between physicians and health care industry in the field of allergy and immunology. Research funding for asthma from the National Institutes of Health slightly decreased from $317 million in 2008 to $313 million in 2019.1 Establishing proper collaborations between physicians and the industry is crucial for improving patient care.
Source: Annals of Allergy, Asthma and Immunology - June 21, 2023 Category: Allergy & Immunology Authors: Anju Murayama Tags: Letters Source Type: research

Industry-sponsored research funding to allergists and clinical immunologists in the United States
Although allergist-immunologists have been facing difficulties to obtain funding for research and educational purposes from the public sector in the United States (US), there is a growing research collaboration and network between physicians and healthcare industry in the field of allergy and immunology. Research funding for asthma from the National Institutes of Health slightly decreased from $317 million in 2008 to $313 million in 2019.1 Establishing proper collaborations between physicians and the industry is crucial for improving patient care.
Source: Annals of Allergy, Asthma and Immunology - June 21, 2023 Category: Allergy & Immunology Authors: Anju Murayama Tags: Letters Source Type: research

Optimizing the Immunogenicity of HIV Vaccines by Adjuvants - NIAID Workshop Report
This report summarizes the highlights of a workshop convened by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), on April 4-5, 2022, to provide a discussion forum for sharing insights on the current status, key challenges, and next steps to advance the current landscape of promising adjuvants in preclinical and clinical human immunodeficiency virus (HIV) vaccine studies. A key goal was to solicit and share recommendations on scientific, regulatory, and operational guidelines for bridging the gaps in rational selection, access, and formulation of clinically relevant adj...
Source: Vaccine - June 18, 2023 Category: Allergy & Immunology Authors: Anjali Singh C ésar Boggiano Michael A Eller Milton Maciel Mary A Marovich Vijay L Mehra Annie X Mo Kentner L Singleton Wolfgang W Leitner Source Type: research

Study provides deeper insight into long COVID
This study is an important step toward defining long COVID beyond any one individual symptom, " said study author Dr. Leora Horwitz, director of the Center for Healthcare Innovation and Delivery Science and co-principal investigator for the RECOVER Clinical Science Core at NYU Langone Health. " This research definition — which may evolve over time — will serve as a foundation for scientific discovery and treatment design. "The researchers say studying the underlying biological mechanisms of long COVID is central to advancing informed interventions and identifying effective treatment strategies. In addition to establish...
Source: The University of Arizona: Health - May 30, 2023 Category: Universities & Medical Training Authors: mittank Source Type: research

A Skin Patch Shows Promise in Treating Kids ’ Peanut Allergies
WASHINGTON — An experimental skin patch is showing promise to treat toddlers who are highly allergic to peanuts—training their bodies to handle an accidental bite. Peanut allergy is one of the most common and dangerous food allergies. Parents of allergic tots are constantly on guard against exposures that can turn birthday parties and play dates into emergency room visits. There is no cure. The only treatment is for children 4 and older who can consume a special peanut powder to protect against a severe reaction. The patch, named Viaskin, aims to deliver that kind of treatment through the skin instead. In a maj...
Source: TIME: Health - May 11, 2023 Category: Consumer Health News Authors: LAURAN NEERGAARD—AP Tags: Uncategorized Diet & Nutrition healthscienceclimate wire Source Type: news

NIH restarts bat virus grant suspended 3 years ago by Trump
Three years after then-President Donald Trump pressured the National Institutes of Health (NIH) to suspend a research grant to a U.S. group studying bat coronaviruses with partners in China, the agency has restarted the award. The new 4-year grant is a stripped-down version of the original grant to the EcoHealth Alliance, a nonprofit research organization in New York City, providing $576,000 per year. That 2014 award included funding for controversial experiments that mixed parts of different bat viruses related to severe acute respiratory syndrome (SARS), the coronavirus that sparked a global outbreak in 2002–04, a...
Source: ScienceNOW - May 8, 2023 Category: Science Source Type: news

Why It Took So Long to Finally Get an RSV Vaccine
Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and Drug Administration (FDA) approved the first vaccine against RSV, from GlaxoSmithKline (GSK), to prevent respiratory disease in people ages 60 and older. The Centers for Disease Control’s vaccine committee will make formal recommendations in June about who should receive the vaccine, but GSK says it currently has enough doses to vaccinate eligible people beginning this fall. In studies involving 25,000 people that GSK...
Source: TIME: Health - May 3, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news

'Black sheep' of helper T cells may hold key to precision allergy treatment
A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision medicine approaches to treating allergies in patients with high levels of Th9.
Source: World Pharma News - May 3, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news